Mustang Bio, Inc. Profile Avatar - Palmy Investing

Mustang Bio, Inc.

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene the…

Biotechnology
US, Worcester [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Mustang Bio, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Mustang Bio, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Mustang Bio, Inc..

End of MBIO's Analysis
CIK: 1680048 CUSIP: 62818Q104 ISIN: US62818Q2030 LEI: - UEI: -
Secondary Listings
MBIO has no secondary listings inside our databases.